Cubist Systematic Strategies, LLC Eli Lilly & CO Put Options Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $23.9 Million - $30 Million	-33,000 Reduced 88.71%	4,200 $3.8 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $12.5 Million - $16.7 Million	-21,100 Reduced 36.19%	37,200 $28.9 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.1 Million - $1.3 Million	-2,100 Reduced 3.48%	58,300 $34 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $3.52 Million - $4.85 Million	8,100 Added 15.49%	60,400 $32.4 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $8.77 Million - $11.7 Million	25,000 Added 91.58%	52,300 $24.5 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $4.63 Million - $5.44 Million	-14,900 Reduced 35.31%	27,300 $9.38 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $6.66 Million - $7.76 Million	20,700 Added 96.28%	42,200 $15.4 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $2.05 Million - $2.33 Million	-6,900 Reduced 24.3%	21,500 $6.95 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $7.92 Million - $9.29 Million	28,400 New	28,400 $9.21 Million

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.